Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression (Q43846868)

27 November 2017

Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression (English)

1 reference

27 November 2017

0 references

0 references

Roshanak Rahimian

1

1 reference

27 November 2017

Gregory P Dubé

2

1 reference

27 November 2017

Warda Toma

3

1 reference

27 November 2017

Nancy Dos Santos

4

1 reference

27 November 2017

Bruce M McManus

5

1 reference

27 November 2017

Cornelis van Breemen

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

European Journal of Pharmacology

27 November 2017

1 reference

27 November 2017

434

1 reference

27 November 2017

3

1 reference

27 November 2017

141-149

1 reference

Endothelial nitric oxide synthase activity in aorta of normocholesterolemic rabbits: regional variation and the effect of estrogen

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

The protective effects of estrogen on the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Coronary heart disease in women--an ounce of prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Sustained Increase in Aortic Endothelial Nitric Oxide Synthase Expression In Vivo in a Model of Chronic High Blood Flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Vascular endothelial cells synthesize nitric oxide from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Gender difference in the basal intracellular Ca2+ concentration in rat valvular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Organization of the bovine gene encoding the endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Induction of calcium-dependent nitric oxide synthases by sex hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

Shear stress regulation of artery lumen diameter in experimental atherogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901546-1

10.1016/S0014-2999(01)01546-1

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference